Alejandro A. Aruffo
30Patents
17h-index
51Co-inventors
80Inventor score
Filing activity: Jan 24, 1991 → Apr 17, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6051228A | Antibodies against human CD40 | Chemistry; Metallurgy | 138 | Expired |
| US5506126A | Rapid immunoselection cloning method | Chemistry; Metallurgy | 120 | Expired |
| US5916560A | Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith | Chemistry; Metallurgy | 91 | Expired |
| US5709859A | Mixed specificity fusion proteins | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6210669A | Methods and compositions for immunomodulation | Human Necessities | 71 | Expired |
| US5849898A | CD40 coding sequences | Chemistry; Metallurgy | 55 | Expired |
| US5540926A | Soluble and its use in B cell stimulation | Chemistry; Metallurgy | 55 | Expired |
| US5993800A | Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand | Chemistry; Metallurgy | 54 | Expired |
| US5747037A | Anti-GP39 antibodies | Chemistry; Metallurgy | 51 | Expired |
| US5876950A | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy | Chemistry; Metallurgy | 50 | Expired |
| US5663151A | Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors | Chemistry; Metallurgy | 46 | Expired |
| US6312693A | Antibodies against human CD40 | Chemistry; Metallurgy | 36 | Expired |
| US5876718A | Methods of inducing T cell non-responsiveness to transplanted tissues and of treating graft-versus-host-disease with anti-gp39 antibodies | Chemistry; Metallurgy | 32 | Expired |
| US6376459B1 | Inhibiting B cell activation with soluble CD40 or fusion proteins thereof | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5830731A | Cloning vector, polylinker and methods | Chemistry; Metallurgy | 25 | Expired |
| US6312692A | Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells | Chemistry; Metallurgy | 22 | Expired |
| US6413514B1 | Methods of using antibodies against human CD40 | Chemistry; Metallurgy | 22 | Expired |
| US5597707A | Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use | Physics | 17 | Expired |
| US7119183B2 | Rapid immunoselection cloning method | Chemistry; Metallurgy | 17 | Expired |
| US6472510B1 | CD40 receptor ligands | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6372215B1 | Monoclonal antibodies to human CD6 | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5945513A | Fusion proteins comprising gp39 and CD8 | Chemistry; Metallurgy | 8 | Expired |
| US5998172A | Anti-CD6 ligand antibodies | Physics | 8 | Expired |
| US6218525A | Nucleic acid encoding CD28 | Chemistry; Metallurgy | 7 | Expired |
| US6046314A | Sp.alpha.: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto | Chemistry; Metallurgy | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.